INVESTORS CONTACT US ABOUT US OUR SCIENCE OUR PIPELINE RESOURCES JOIN US View our webcast on the role of the melanocortin agonists in ocular indications PALATIN DELIVERS TREATMENTS THAT HARNESS THE HEALING POWER OF THE MELANOCORTIN SYSTEM .st0{fill:url(#Rectangle_25_1_);} .st1{fill:url(#Rectangle_24_1_);} .st2{fill:url(#Path_358_1_);} .st3{fill:url(#Path_359_1_);} .st4{fill:url(#Path_360_1_);} .st5{fill:url(#Path_361_1_);} .st6{fill:url(#Ellipse_10_1_);} .st7{fill:none;stroke:#FFFFFF;stroke-width:2;} .st8{fill:url(#Rectangle_22_1_);} .st9{fill:none;stroke:#FFFFFF;stroke-width:2;stroke-miterlimit:10;} .st10{fill:url(#Rectangle_171_1_);} .st11{fill:url(#Rectangle_185_1_);} .st12{fill:url(#Rectangle_180_1_);} .st13{fill:url(#Rectangle_181_1_);} .st14{fill:url(#Rectangle_182_1_);} .st15{fill:url(#Rectangle_183_1_);} .st16{fill:url(#Rectangle_184_1_);} .st17{fill:url(#Polygon_5_1_);} .st18{fill:url(#Ellipse_20_1_);} .st19{fill:none;stroke:#FCFCFC;stroke-width:2;stroke-linecap:round;stroke-linejoin:round;} We discover and develop novel therapeutics for patients living with inflammatory and autoimmune conditions. Chronic inflammation is a consequence of many diseases, but current treatments often do not strike the right balance between efficacy, safety, and tolerability—leading to frustration for the patient and the physician alike. By leveraging our expansive knowledge of the melanocortin system, we design our therapeutics to directly engage one of the body’s natural pathways to resolve harmful inflammation, providing a novel approach that allows affected tissue time to heal. ABOUT US OUR SCIENCE Discover how activating the melanocortin system can help resolve harmful inflammation. EXPLORE OUR SCIENCE OUR PIPELINE Armed with a novel strategy to resolve harmful inflammation, we are focused on developing treatments for inflammatory and autoimmune diseases, starting with ocular conditions. VIEW PIPELINE VYLEESI® (bremelanotide injection) LEARN MORE JOIN US At Palatin, we drive our culture with science. Our employees have unparalleled expertise related to the melanocortin system allowing them to develop potent, selective treatments for patients with unmet medical needs. GET STARTED NEWS Our press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships. VIEW ALL PRESS RELEASES RESOURCES Take a look at the latest on Palatin across our media publications, posters, and presentations. VIEW OUR RESOURCES 4-B Cedar Brook Drive Cedar Brook Corporate Center Cranbury, NJ 08512 © 2021 PALATIN | ALL RIGHTS RESERVED | PRIVACY POLICY | TERMS OF USE | ACCESSIBILITY STATEMENT